Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Quarterly figures for Northwest Biotherapeutics Inc, with source filings when available.
65 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
Northwest Biotherapeutics Inc has filed its 10-Q within 40 to 45 days of period end across its last 8 quarters. The 10-K runs 59 to 105 days.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | $807.00K | +516.0% | -$0.01 | |
| Q1 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | $494.00K | +31.7% | $0.00 | |
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | Apr 15, 2026 | 105 d | 10-K | $672.00K | +190.9% | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 14, 2025 | ||||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 31, 2025 | 90 d | 10-K | $231.00K | −48.1% | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 12, 2024 | ||||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Mar 5, 2024 | 65 d | 10-K | $445.00K | −25.5% | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 9, 2023 | ||||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Feb 28, 2023 | 59 d | 10-K | $597.00K | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 9, 2022 | ||||||
| FY 2021 | |||||||||
| Q4 2021derived | Dec 31, 2021 | — | Mar 1, 2022 | 60 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 15, 2021 | ||||||
| FY 2020 | |||||||||
| Q4 2020derived | Dec 31, 2020 | — | Mar 31, 2021 | 90 d | 10-K | $503.00K | −43.9% | — | |
| Q3 2020 | Sep 30, 2020 | — | Jan 15, 2021 | ||||||
| FY 2019 | |||||||||
| Q4 2019derived | Dec 31, 2019 | — | Mar 16, 2020 | 76 d | 10-K | $897.00K | — | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 12, 2019 | ||||||
| FY 2018 | |||||||||
| Q4 2018derived | Dec 31, 2018 | — | Apr 2, 2019 | 92 d | 10-K | — | — | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 16, 2018 | 47 d | 10-Q | ||||
| FY 2017 | |||||||||
| Q4 2017derived | Dec 31, 2017 | — | Apr 17, 2018 | 107 d | 10-K | $32.00K | −54.9% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 20, 2017 | ||||||
| FY 2016 | |||||||||
| Q4 2016derived | Dec 31, 2016 | — | Apr 17, 2017 | 107 d | 10-K | $71.00K | −91.8% | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 10, 2016 | ||||||
| FY 2015 | |||||||||
| Q4 2015 | Dec 31, 2015 | — | Mar 16, 2016 | 76 d | 10-K | $863.00K | −1.0% | -$0.27 | |
| Q3 2015 | Sep 30, 2015 | — | Nov 9, 2015 | 40 d | |||||
| FY 2014 | |||||||||
| Q4 2014 | Dec 31, 2014 | — | Mar 17, 2015 | 76 d | 10-K | $872.00K | — | -$0.64 | |
| Q3 2014 | Sep 30, 2014 | — | Nov 19, 2014 | 50 d | |||||
| FY 2013 | |||||||||
| Q4 2013derived | Dec 31, 2013 | — | Apr 1, 2014 | 91 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 15, 2013 | ||||||
| FY 2012 | |||||||||
| Q4 2012derived | Dec 31, 2012 | — | Apr 8, 2013 | 98 d | 10-K | $322.00K | — | — | |
| Q3 2012 | Sep 30, 2012 | — | Nov 14, 2012 | ||||||
| FY 2011 | |||||||||
| Q4 2011derived | Dec 31, 2011 | — | Apr 13, 2012 | 104 d | 10-K | $0.00 | — | — | |
| Q3 2011 | Sep 30, 2011 | — | Nov 14, 2011 | ||||||
| FY 2010 | |||||||||
| Q4 2010derived | Dec 31, 2010 | — | Apr 21, 2011 | 111 d | 10-K | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | Nov 22, 2010 | 53 d | 10-Q | ||||
| 45 d |
| 10-Q |
| $200.00K |
| −44.0% |
| -$0.02 |
| Q2 2025 | Jun 30, 2025 | — | Aug 14, 2025 | 45 d | 10-Q | $131.00K | −74.3% | -$0.01 |
|---|
| Q1 2025 | Mar 31, 2025 | — | May 15, 2025 | 45 d | 10-Q | $375.00K | +32.0% | -$0.01 |
|---|
| 43 d |
| 10-Q |
| $357.00K |
| −12.1% |
| -$0.02 |
| Q2 2024 | Jun 30, 2024 | — | Aug 9, 2024 | 40 d | 10-Q | $510.00K | +153.7% | -$0.02 |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 10, 2024 | 40 d | 10-Q | $284.00K | −67.7% | -$0.02 |
|---|
| 40 d |
| 10-Q |
| $406.00K |
| +97.1% |
| -$0.02 |
| Q2 2023 | Jun 30, 2023 | — | Aug 9, 2023 | 40 d | 10-Q | $201.00K | −57.9% | -$0.01 |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 10, 2023 | 40 d | 10-Q | $880.00K | +118.4% | -$0.01 |
|---|
| 40 d |
| 10-Q |
| $206.00K |
| −41.1% |
| -$0.03 |
| Q2 2022 | Jun 30, 2022 | — | Aug 9, 2022 | 40 d | 10-Q | $477.00K | +14.7% | -$0.01 |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 10, 2022 | 40 d | 10-Q | $403.00K | +68.6% | -$0.01 |
|---|
| 46 d |
| 10-Q |
| $350.00K |
| +62.0% |
| -$0.01 |
| Q2 2021 | Jun 30, 2021 | — | Aug 16, 2021 | 47 d | 10-Q | $416.00K | +20,700.0% | -$0.01 |
|---|
| Q1 2021 | Mar 31, 2021 | — | May 17, 2021 | 47 d | 10-Q | $239.00K | −58.1% | $0.00 |
|---|
| 107 d |
| 10-Q |
| $216.00K |
| −63.6% |
| -$0.26 |
| Q2 2020 | Jun 30, 2020 | — | Aug 10, 2020 | 41 d | 10-Q | $2.00K | −99.7% | -$0.08 |
|---|
| Q1 2020 | Mar 31, 2020 | — | Jun 24, 2020 | 85 d | 10-Q | $570.00K | +68.1% | $0.00 |
|---|
| 43 d |
| 10-Q |
| $593.00K |
| +30.9% |
| -$0.01 |
| Q2 2019 | Jun 30, 2019 | — | Aug 9, 2019 | 40 d | 10-Q | $581.00K | +109.0% | $0.00 |
|---|
| Q1 2019 | Mar 31, 2019 | — | May 10, 2019 | 40 d | 10-Q | $339.00K | +156.8% | -$0.04 |
|---|
| $453.00K |
| +206.1% |
| $0.02 |
| Q2 2018 | Jun 30, 2018 | — | Aug 14, 2018 | 45 d | 10-Q | $278.00K | +215.9% | -$0.06 |
|---|
| Q1 2018 | Mar 31, 2018 | — | May 16, 2018 | 46 d | 10-Q | $132.00K | +94.1% | -$0.09 |
|---|
| 51 d |
| 10-Q |
| $148.00K |
| −6.9% |
| -$0.08 |
| Q2 2017 | Jun 30, 2017 | — | Aug 21, 2017 | 52 d | 10-Q | $88.00K | −43.9% | -$0.05 |
|---|
| Q1 2017 | Mar 31, 2017 | — | May 15, 2017 | 45 d | 10-Q | $68.00K | −71.2% | -$0.08 |
|---|
| 41 d |
| 10-Q |
| $159.00K |
| −45.4% |
| -$0.28 |
| Q2 2016 | Jun 30, 2016 | — | Aug 9, 2016 | 40 d | 10-Q | $157.00K | −59.8% | -$0.16 |
|---|
| Q1 2016 | Mar 31, 2016 | — | May 11, 2016 | 41 d | 10-Q | $236.00K | +21.6% | -$0.06 |
|---|
| 10-Q |
| $291.00K |
| −50.0% |
| $0.25 |
| Q2 2015 | Jun 30, 2015 | — | Aug 10, 2015 | 41 d | 10-Q | $391.00K | — | -$0.88 |
|---|
| Q1 2015 | Mar 31, 2015 | — | May 11, 2015 | 41 d | 10-Q | $194.00K | — | -$0.67 |
|---|
| 10-Q |
| $582.00K |
| +45.5% |
| -$0.35 |
| Q2 2014 | Jun 30, 2014 | — | Aug 15, 2014 | 46 d | 10-Q | $0.00 | −100.0% | -$0.45 |
|---|
| Q1 2014 | Mar 31, 2014 | — | May 15, 2014 | 45 d | 10-Q | $0.00 | −100.0% | -$0.88 |
|---|
| 46 d |
| 10-Q |
| $400.00K |
| +233.3% |
| -$0.65 |
| Q2 2013 | Jun 30, 2013 | — | Aug 14, 2013 | 45 d | 10-Q | $272.00K | −17.6% | -$0.40 |
|---|
| Q1 2013 | Mar 31, 2013 | — | May 15, 2013 | 45 d | 10-Q | $137.00K | — | -$0.54 |
|---|
| 45 d |
| 10-Q |
| $120.00K |
| +1,100.0% |
| -$1.50 |
| Q2 2012 | Jun 30, 2012 | — | Aug 14, 2012 | 45 d | 10-Q | $330.00K | — | -$0.06 |
|---|
| Q1 2012 | Mar 31, 2012 | — | May 21, 2012 | 51 d | 10-Q | $0.00 | — | -$1.06 |
|---|
| 45 d |
| 10-Q |
| $10.00K |
| ±0.0% |
| $0.06 |
| Q2 2011 | Jun 30, 2011 | — | Aug 15, 2011 | 46 d | 10-Q | $0.00 | — | -$0.15 |
|---|
| Q1 2011 | Mar 31, 2011 | — | May 20, 2011 | 50 d | 10-Q | $0.00 | — | — |
|---|
| $10.00K |
| — |
| -$0.08 |
| Q2 2010 | Jun 30, 2010 | — | Aug 17, 2010 | 48 d | 10-Q | $0.00 | — | -$0.14 |
|---|
